An engineered ACE2 decoy neutralizes SARS-CoV-2 Omicron BA.5 in vitro and in vivo
H. B., L. G. W., et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
L. Zhang, S. Dutta, et al.
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
A. A. Ordonez, C. K. Bullen, et al.
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
G. Shi, T. Li, et al.
Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)
A. J. M. Aabakke, T. G. Petersen, et al.

